Sunday, January 30, 2011

Novartis 4Q10 1/27/2011


Novartis released earnings Thursday, and reported $14.2 billion in sales for the fourth quarter and $50.6 billion in sales for year 2010. Novartis increased their fourth quarter sales by $1.3 billion, or 10%, from fourth quarter 2009, and increased their annual sales by $6.3 billion, representing an increase of 14%. In addition to sales, profit also exceeded last year’s numbers, but did not exceed analyst expectations. Profits for the year jumped to $10 billion, representing an increase of 18% over the previous year’s $8.4 billion in profits. Quarterly profits fell by 2% from $2.32 billion to $2.27 billion.
Despite fairly positive numbers, Novartis shares dropped 2.7%, as the reported earnings did not meet analyst recommendations. Wall Street analysts had expected Novartis to report earnings of $1.25 per share, but the company only returned $1.14. The earnings underperformed analyst expectations mainly due to restructuring charges and currency impacts. However, the company praised its acquisition of Alcon, and expects the new eye-care division to be a driver of earnings growth in the future. In addition, the company saw 13 major products approved, and filed 16 new products during the 2010 year. Novartis saw strong growth in its generic division, which saw sales increase 14% from $7.5 billion to $8.5 billion. The generic arm of Novartis capitalized on patent expirations of other large pharmaceutical companies such as Sanofi-Aventis and Merck. Novartis created generic version of Sanofi-Aventis’ Lovenox, a blood thinning drug, and Cozaar, a major cardiovascular drug created by Merck. Novartis also has some potential blockbuster drugs in the pipeline. The company is currently working on an experimental respiratory drug called QVA149, which is expected to be a major drug if it is approved. A new blockbuster drug is necessary, as Novartis is about to face patent expirations of some of its biggest drugs. Diovan, the company’s best-selling heart drug, drove $6 billion in sales in 2009, and is now facing patent expiration in 2011. In addition, Gilvec drove nearly $4 billion in sales, and is facing patent expiration in 2015.
                In conclusion, Novartis saw increase in annual and quarterly sales, and an increase in annual earnings. Despite these increases, the company missed analyst expectations, and the stock dropped by 2.7%. Going forward, the company needs to find a new blockbuster drug to help alleviate the earnings loss that will come when two major drugs, Diovan and Gilvec, face patent expiration. Considering the patent expirations the company is facing, and the uncertainty surrounding healthcare reform, I am cautious about Novartis’ return potential and its place in our portfolio.

-Ryan M. Kennedy

Friday, January 28, 2011

Ford 4Q10 Earnings 1/27/11

Ford Motor reported its best full-year profit in more than a decade, but weaker-than-expected fourth-quarter earnings. Net profit for 2010 totaled $6.6 billion, or $1.66 per share, an increase of $3.8 billion above 2009. However, Ford’s fourth -quarter earnings fell 79% to $190 million. These results include a previously disclosed one time charge of $960 million as part of its balance sheet restructuring. Ford fell short of analyst earnings estimates of $0.48 by 37%, reporting earnings of only $0.30. Ford had beaten expectations for each of the past seven quarters.

4Q earnings also showed Ford Europe’s operating loss of $51 million, compared with a $253 million profit a year earlier. Chief financial officer, Lewis Booth described the surprising results in Europe as “a little bit of a disappointment”. He also said: “We were very clear, though, that we were not going to chase market share.” The European operation is expected to return to profitability this year.

In 2010, Ford paid over $14.5 billion in debt, ending the year with $19.1 billion in debt. Cash revenues totaled $20.5 billion shifting Ford from $8.7 billion in net debt a year ago to net cash of $1.4 billion. Ford plans to continue to reduce the amount of debt they have on their balance sheet through 2011.

Ford shares were hit by the weak earnings, falling by $2.39 or 12.72% to 16.40. Other then the stock plunge the earnings report for Ford was great. Ford showed its ability to grow profits in 2010 and is expecting to continue in 2011. A key concern looking to the future will be whether or not Ford can maintain healthy profit margins.

- Michael Biagi, Junior Analyst

Ford 4Q10 Earnings 1/27/11


Ford Motor reported its best full-year profit in more than a decade, but weaker-than-expected fourth-quarter earnings. Net profit for 2010 totaled $6.6 billion, or $1.66 per share, an increase of $3.8 billion above 2009. However, Ford’s fourth -quarter earnings fell 79% to $190 million. These results include a previously disclosed one time charge of $960 million as part of its balance sheet restructuring. Ford fell short of analyst earnings estimates of $0.48 by 37%, reporting earnings of only $0.30. Ford had beaten expectations for each of the past seven quarters.

4Q earnings also showed Ford Europe’s operating loss of $51 million, compared with a $253 million profit a year earlier. Chief financial officer, Lewis Booth described the surprising results in Europe as “a little bit of a disappointment”. He also said: “We were very clear, though, that we were not going to chase market share.” The European operation is expected to return to profitability this year.
In 2010, Ford paid over $14.5 billion in debt, ending the year with $19.1 billion in debt. Cash revenues totaled $20.5 billion shifting Ford from $8.7 billion in net debt a year ago to net cash of $1.4 billion. Ford plans to continue to reduce the amount of debt they have on their balance sheet through 2011.
Ford shares were hit by the weak earnings falling by $2.39 or 12.72% to 16.40. Other then the stock plunge the earnings report for Ford was great. Ford showed its ability to grow profits in 2010 and is expecting to continue in 2011. A key concern looking to the future will be whether or not Ford can maintain healthy profit margins.  
- Michael Biagi, Junior Analyst

Verizon Communications (VZ)- Earnings Release

Verizon Communications released fourth quarter earnings of $0.54 per share missing analyst expectations of $0.55 per share.

Verizon Wireless has experienced a 7.7% increase in service revenue and a 25.5% increase in its data revenue from 4th Quarter 2009.

Verizon’s Wireline segment added 197,000 Fios internet users and 182,000 Fios TV subscribers in the 4th Quarter of FY 2010.

On January 11th 2010 Verizon Wireless announced that it would begin carrying the iPhone 4 which will be available to Verizon Wireless subscribers in February of 2011. Verizon’s ability to begin distributing the iPhone 4 as one of its premier mobile devices is expected to provide substantial wireless service and data growth. Despite the iPhone’s ability to increase customer and data growth, many analysts are concerned of Verizon’s ability to support the influx of data usage. Verizon Wireless has been a market leader in service quality over the last years. Deterioration of Verizon’s wireless network could potentially cause material problems for the company’s growth and ability to maintain favorable churn. Management has stated that it is fully confident in its network, however this is an issue that UASBIG analysts will continue to monitor closely.

~Chad

Thursday, January 27, 2011

CAT 4Q10 Earnings 01/27/11 - Jeremy Pellizzari

Caterpillar Inc. reported 4Q revenues of $12.8 billion, which was a 69% increase from the year before. For the fiscal year, CAT reported earnings of $42.6 billion, an increase of 31% from the prior year. The 4Q earnings showed profit nearly quadrupled year over year to $968 million, which equates to an increase of EPS from $.36 to $1.47. Caterpillar managed to beat analysts’ expectations by nearly 14% and has managed to beat earnings for eight straight quarters. Much of this can be attributed to machinery sales being up 88% and engine sales up 36%. Throughout the year, CAT raised production levels each quarter, to the point that there 4Q shipments of machinery were double that of the prior year.

Looking to the future, CAT appears to maintain strong growth into 2011 riding out the growth in developing countries. CFO Edward Rapp is quoted as saying “We’re very optimistic about what’s going on in the developing parts of the world.” The outlook for 2011 does not include two pending acquisitions of Bucyrus International Inc. and Motoren-Werke Mannheim Holding, but still forecasts earnings near $6 per share, a 45% increase from the $4.15 per share in 2010. They are forecasting sales to top $50 billion which would be a 17% increase from 2010. Some of the risks they have identified going into 2011 are rising prices of raw materials, global divergence, and central banks in developed economies tightening economic policies. In regards to raw material prices, Caterpillar reports they believe that total costs of material are expected to be “relatively flat.” They justify this with the fact that steel accounts for only 20% of material costs and the suppliers through which they buy parts have cut costs of labor by becoming more efficient. Look for Caterpillar to have a strong year in 2011 and continue to be the world’s largest manufacturer of construction and mining equipment.

Jeremy Pellizzari - Junior Analyst

Western Digital Q2 Earnings

Western Digital reported Q2 earnings with total revenue of $2.475 billion and a net income of $225 million, or 96 cents per share, beating analysts’ estimates by 38 cents per share. Western Digital, which competes with larger rival Seagate Technology, said hard-drive unit shipments in the quarter rose 5 percent to 52.2 million. Chief Executive John Coyne said the company’s results reflected “solid execution and an improvement in hard drive industry conditions compared with the prior two quarters.” However, the company warned that tablets which use flash memory rather than hard-drive storage - would reduce growth in shipments of low-end laptops by 10-20 percent over the next few quarters. Western Digital expects revenue to range from $2.2 billion to $2.25 million in the third quarter.

Vladimir Pantilei,Junior Technology Analyst

LIFE upward trend looks to continue

In the past 52 weeks, shares of Life Technologies have traded between a low of $41.10 and a high of $57.25 and are now at $54.49, which is 33% above that low price. Life Technologies is currently above its 50-day moving average of $53.66 and above its 200-day moving average of $49.64. In the last five trading sessions, the 50-day MA has climbed 0.32% while the 200-day MA has remained constant.

-Jesus